NGA
AZN icon

Naples Global Advisors’s AstraZeneca AZN Stock Holding History

Naples Global Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Sell
24,721
-361
-1% -$67.9K 0.29% 89
2026
Q1 		$4.95M Sell
25,082
-540
-2% -$104K 0.36% 80
2025
Q4 		$4.71M Sell
25,622
-895
-3% -$157K 0.35% 80
2025
Q3 		$4.07M Sell
26,517
-128
-0.5% -$19.4K 0.32% 88
2025
Q2 		$3.72M Sell
26,645
-338
-1% -$47.4K 0.32% 89
2025
Q1 		$3.97M Sell
26,983
-407
-1% -$58.9K 0.38% 80
2024
Q4 		$3.59M Buy
27,390
+151
+0.6% +$21.1K 0.34% 90
2024
Q3 		$4.24M Buy
27,239
+350
+1% +$56.5K 0.39% 75
2024
Q2 		$4.19M Buy
26,889
+185
+0.7% +$27.8K 0.42% 72
2024
Q1 		$3.62M Buy
26,704
+2,395
+10% +$317K 0.37% 80
2023
Q4 		$3.27M Buy
24,309
+1,957
+9% +$254K 0.36% 82
2023
Q3 		$3.03M Buy
22,352
+928
+4% +$127K 0.37% 80
2023
Q2 		$3.07M Sell
21,424
-21
-0.1% -$3.09K 0.36% 84
2023
Q1 		$2.98M Buy
21,445
+452
+2% +$60.8K 0.37% 82
2022
Q4 		$2.85M Buy
20,993
+462
+2% +$57.9K 0.36% 82
2022
Q3 		$2.25M Buy
20,531
+125
+0.6% +$15.9K 0.31% 101
2022
Q2 		$2.7M Buy
20,406
+339
+2% +$44.5K 0.35% 89
2022
Q1 		$2.66M Buy
20,067
+300
+2% +$36K 0.31% 97
2021
Q4 		$2.3M Buy
19,767
+88
+0.4% +$10.4K 0.27% 112
2021
Q3 		$2.36M Buy
19,679
+200
+1% +$23.3K 0.31% 96
2021
Q2 		$2.33M Buy
19,479
+1,587
+9% +$174K 0.32% 94
2021
Q1 		$1.78M Sell
17,892
-32
-0.2% -$3.22K 0.27% 115
2020
Q4 		$1.79M Buy
17,924
+287
+2% +$30.4K 0.3% 99
2020
Q3 		$1.93M Buy
17,637
+133
+0.8% +$14.8K 0.38% 80
2020
Q2 		$1.85M Buy
17,504
+1,200
+7% +$124K 0.4% 74
2020
Q1 		$1.46M Buy
16,304
+350
+2% +$32.9K 0.38% 80
2019
Q4 		$1.59M Sell
15,954
-38
-0.2% -$3.58K 0.33% 95
2019
Q3 		$1.43M Hold
15,992
– – 0.33% 96
2019
Q2 		$1.32M Buy
15,992
+450
+3% +$35.3K 0.32% 101
2019
Q1 		$1.26M Sell
15,542
-385
-2% -$30.3K 0.32% 105
2018
Q4 		$1.22M Sell
15,927
-890
-5% -$69.5K 0.35% 93
2018
Q3 		$1.33M Buy
16,817
+575
+4% +$43.5K 0.35% 95
2018
Q2 		$1.14M Buy
16,242
+1,050
+7% +$75.5K 0.32% 107
2018
Q1 		$1.06M Buy
15,192
+125
+0.8% +$8.66K 0.32% 111
2017
Q4 		$1.05M Buy
15,067
+876
+6% +$59.1K 0.31% 112
2017
Q3 		$962K Buy
14,191
+325
+2% +$20.5K 0.32% 115
2017
Q2 		$945K Hold
13,866
– – 0.34% 110
2017
Q1 		$864K Sell
13,866
-1,101
-7% -$64.1K 0.31% 122
2016
Q4 		$818K Sell
14,967
-300
-2% -$17K 0.32% 120
2016
Q3 		$1M Hold
15,267
– – 0.39% 94
2016
Q2 		$922K Buy
15,267
+1,050
+7% +$61K 0.38% 103
2016
Q1 		$801K Buy
14,217
+350
+3% +$21K 0.34% 112
2015
Q4 		$942K Hold
13,867
– – 0.46% 87
2015
Q3 		$882K Hold
13,867
– – 0.45% 87
2015
Q2 		$883K Hold
13,867
– – 0.42% 95
2015
Q1 		$949K Hold
13,867
– – 0.45% 90
2014
Q4 		$976K Buy
13,867
+35
+0.3% +$2.51K 0.52% 79
2014
Q3 		$988K Buy
13,832
+600
+5% +$43.9K 0.58% 64
2014
Q2 		$983K Buy
13,232
+150
+1% +$10.8K 0.58% 55
2014
Q1 		$849K Buy
13,082
+200
+2% +$12.9K 0.52% 61
2013
Q4 		$765K Buy
+12,882
New +$700K 0.51% 67

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Naples Global Advisors's AZN Position: Q2 2026 in Review

Naples Global Advisors reduced its AstraZeneca (AZN) stake by 1.4% in Q2 2026, selling an estimated $67.9K and leaving 24,721 shares worth $4.69M. The position accounts for 0.29% of the portfolio, ranked #89.

Naples Global Advisors first reported a position in AZN in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.95M in Q1 2026. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Naples Global Advisors held 24,721 shares of AstraZeneca worth $4.69M as of Q2 2026.
  • Naples Global Advisors sold 361 AstraZeneca shares in Q2 2026, an estimated $67.9K.
  • AstraZeneca made up 0.29% of Naples Global Advisors's portfolio in Q2 2026, its #89 holding.
  • Naples Global Advisors first reported a position in AstraZeneca in Q4 2013 and has held it in 51 quarters since.
  • Naples Global Advisors's AstraZeneca position peaked at $4.95M in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.